A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.

Autor: Chavda SJ; UCL Cancer Institute, London, UK., Maciocia PM; UCL Cancer Institute, London, UK., Mesiri P; CRUK & UCL Cancer Trials Centre, London, UK., Counsell N; CRUK & UCL Cancer Trials Centre, London, UK., Kothari J; University College London Hospitals NHS Foundation trusts, London, UK., Bird A; University College London Hospitals NHS Foundation trusts, London, UK., Mariner C; University College London Hospitals NHS Foundation trusts, London, UK., Chew A; University College London Hospitals NHS Foundation trusts, London, UK., Clesham K; University College London Hospitals NHS Foundation trusts, London, UK., Moore S; University College London Hospitals NHS Foundation trusts, London, UK., Percy L; University College London Hospitals NHS Foundation trusts, London, UK., Rismani A; University College London Hospitals NHS Foundation trusts, London, UK., D'Sa S; University College London Hospitals NHS Foundation trusts, London, UK., Rabin N; University College London Hospitals NHS Foundation trusts, London, UK., Popat R; UCL Cancer Institute, London, UK.; University College London Hospitals NHS Foundation trusts, London, UK., Yong K; UCL Cancer Institute, London, UK.; University College London Hospitals NHS Foundation trusts, London, UK.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (2), pp. 350-353. Date of Electronic Publication: 2018 Jul 09.
DOI: 10.1111/bjh.15487
Databáze: MEDLINE
Externí odkaz: